New Hope for Serious Infections
Cidara is a clinical-stage biotechnology company focused on the development of novel anti-infectives that have the potential to transform the standard of care and save or improve patients’ lives.
Company OverviewRezafunginCloudbreak™Cidara is a clinical-stage biotechnology company focused on the development of novel anti-infectives that have the potential to transform the standard of care and save or improve patients’ lives.
Company OverviewRezafunginCloudbreak™Cidara News + Events
There is an urgent and growing need not only for improved anti-infectives but also for entirely new therapeutic approaches to treat and prevent fungal, bacterial, and viral pathogens, particularly for today’s increasingly complex and immunocompromised patients.
Our initial portfolio is comprised of proprietary product candidates for the treatment and prevention of serious fungal and bacterial infections.